尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Christophe Douat, 管理委员会主席. Insider active across 1 company, notably MEDINCELL. Cumulatively, 1 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €600k. History available since 2 May 2023. The latest transaction was disclosed on 2 May 2023 (Cession). Regulator: AMF. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Christophe Douat is the Chairman of the Executive Board at Medincell. In this role, he oversees the company's operations and is responsible for implementing the overall strategy. His experience in the pharmaceutical sector allows him to guide the company in its strategic decisions. He plays a key role in the future direction of Medincell.